1. 3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs). (September 2015) Authors: Horn, L.; Brahmer, J.; Reck, M.; Borghaei, H.; Spigel, D.R.; Steins, M.; Ready, N.E.; Chow, L.Q.; Vokes, E.E.; Felip, E.; Holgado, E.; Barlesi, F.; Kohlhäufl, M.J.; Burgio, M.A.; Fayette, J.; Gettinger, S.N.; Harbison, C.T.; Li, A.; Finckenstein, F.G.; Paz-Ares, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 513 Safety, activity and biomarkers of atezolizumab (MPDL3280A) with platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): A Phase Ib study. (September 2015) Authors: Giaccone, G.; Camidge, D.R.; Liu, S.V.; Powderly, J.; Hodi, F.S.; Gettinger, S.N.; Heist, R.S.; Liu, B.; Wallin, J.; Funke, R.; Waterkamp, D.; Ready, N.E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3097 Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC). (September 2015) Authors: Hellmann, M.D.; Rizvi, N.; Gettinger, S.N.; Goldman, J.; Chow, L.Q.; Juergens, R.; Borghaei, H.; Brahmer, J.; Shen, Y.; Harbison, C.T.; Nathan, F.; Ready, N.E.; Antonia, S.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3061 Assessment of Brigatinib (AP26113) CNS Activity in Patients (Pts) With ALK+ NSCLC and intracranial metastases in a Phase 1/2 Study. (September 2015) Authors: Camidge, D.R.; Bazhenova, L.A.; Salgia, R.; Langer, C.J.; Gold, K.; Rosell, R.; Shaw, A.T.; Weiss, G.J.; Dorer, D.J.; Rivera, V.M.; Conlan, M.G.; Kerstein, D.; Gettinger, S.N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC). (September 2015) Authors: Gettinger, S.N.; Horn, L.; Ramalingam, S.S.; Spigel, D.R.; Paz-Ares, L.; Paik, P.; Reck, M.; Reckamp, K.; Mazières, J.; Stinchcombe, T.; Lynch, M.; Brahmer, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses. (September 2015) Authors: Gettinger, S.N.; Hellmann, M.D.; Shepherd, F.A.; Antonia, S.J.; Brahmer, J.; Chow, L.Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N.E.; Gerber, D.E.; Nathan, F.; Shen, Y.; Harbison, C.T.; Rizvi, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases. (January 2015) Authors: Gettinger, S.N.; Bazhenova, L.; Salgia, R.; Langer, C.J.; Gold, K.A.; Rosell, R.; Shaw, A.T.; Weiss, G.J.; Narasimhan, N.I.; Dorer, D.J.; Rivera, V.M.; Clackson, T.; Haluska, F.G.; Camidge, D.R. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases. Issue 1 (January 2015) Authors: Gettinger, S.N.; Bazhenova, L.; Salgia, R.; Langer, C.J.; Gold, K.A.; Rosell, R.; Shaw, A.T.; Weiss, G.J.; Narasimhan, N.I.; Dorer, D.J.; Rivera, V.M.; Clackson, T.; Haluska, F.G.; Camidge, D.R. Journal: Lung cancer Issue: Volume 87:Issue 1(2015:Jan.) Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 56 Efficacy and safety of brigatinib (AP26113) in ALK+ NSCLC: phase 1/2 trial results. (January 2016) Authors: Gettinger, S.N.; Bazhenova, L.A.; Salgia, R.; Langer, C.J.; Gold, K.; Rosell, R.; Shaw, A.T.; Weiss, G.J.; Dorer, D.J.; Rivera, V.M.; Kerstein, D.; Camidge, D.R. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗